留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

器官移植与疫苗接种

陈松 张伟杰

陈松, 张伟杰. 器官移植与疫苗接种[J]. 器官移植, 2022, 13(1): 6-11. doi: 10.3969/j.issn.1674-7445.2022.01.002
引用本文: 陈松, 张伟杰. 器官移植与疫苗接种[J]. 器官移植, 2022, 13(1): 6-11. doi: 10.3969/j.issn.1674-7445.2022.01.002
Chen Song, Zhang Weijie. Organ transplantation and vaccination[J]. ORGAN TRANSPLANTATION, 2022, 13(1): 6-11. doi: 10.3969/j.issn.1674-7445.2022.01.002
Citation: Chen Song, Zhang Weijie. Organ transplantation and vaccination[J]. ORGAN TRANSPLANTATION, 2022, 13(1): 6-11. doi: 10.3969/j.issn.1674-7445.2022.01.002

器官移植与疫苗接种

doi: 10.3969/j.issn.1674-7445.2022.01.002
基金项目: 

中国医学科学院中央级公益性科研院所基本科研业务费专项资金资助 2019PT320014

详细信息
    作者简介:

    陈松,男,1980年生,博士,副教授、副主任医师,研究方向为肾移植、移植免疫、异种移植,Email:chensong@tjh.tjmu.edu.cn

    张伟杰,华中科技大学同济医学院附属同济医院三级教授、主任医师、博士研究生导师。现任华中科技大学同济医学院附属同济医院器官移植研究所副所长。兼任湖北省医学会器官移植学分会主任委员、中国医疗保健国际交流促进会肾移植分会副主任委员、中华医学会器官移植学分会委员、中国医师协会器官移植医师分会委员、中国研究型医院学会移植医学分会委员、中国生物医学工程学会透析移植分会常务委员、武汉医学会器官移植学分会常务委员。兼任《器官移植》《中华器官移植杂志》《中华移植杂志(电子版)》《实用器官移植电子杂志》《国际移植与血液净化杂志》等多种专业杂志编委。在腹部器官移植领域拥有丰富的临床和科研经验,曾主持3项国家自然科学基金,参编《联合器官移植学》《移植医学-从基础到临床》《现代器官移植学》《器官移植临床指南》《器官移植学》等专著近10部。2017年主持的项目“公民逝世后器官捐献体系的建立及肝肾移植”获湖北省科技进步一等奖

    通讯作者:

    张伟杰, Email: wjzhangtj@126.com

  • 中图分类号: R617, R392

Organ transplantation and vaccination

More Information
  • 摘要: 器官移植受者术后需长期服用免疫抑制剂,因此免疫功能低下,是感染的高危人群,且其住院率、危重率和病死率均较高。接种疫苗是目前公认的预防感染的有效方式,器官移植受者可以根据实际情况进行疫苗接种。但器官移植受者对疫苗的敏感性降低,其接种疫苗的种类、接种方式和时机一直是临床研究的热点。本文就器官移植受者疫苗接种的一般原则、器官移植受者特定疫苗的接种以及器官移植受者新型冠状病毒疫苗的接种做一简要述评,以期为器官移植受者的疫苗接种提供参考,并特别关注全球新型冠状病毒肺炎疫情大流行的情况下器官移植受者接种新型冠状病毒疫苗的现状。

     

  • [1] MOMBELLI M, KAMPOURI E, MANUEL O. Influenza in solid organ transplant recipients: epidemiology, management, and outcomes[J]. Expert Rev Anti Infect Ther, 2020, 18(2): 103-112. DOI: 10.1080/14787210.2020.1713098.
    [2] MARINELLI TM, KUMAR D. Influenza virus infection and transplantation[J]. Transplantation, 2021, 105(5): 968-978. DOI: 10.1097/TP.0000000000003486.
    [3] Columbia University Kidney Transplant Program. Early description of coronavirus 2019 disease in kidney transplant recipients in New York[J]. J Am Soc Nephrol, 2020, 31(6): 1150-1156. DOI: 10.1681/ASN.2020030375.
    [4] AKALIN E, AZZI Y, BARTASH R, et al. COVID-19 and kidney transplantation[J]. N Engl J Med, 2020, 382(25): 2475-2477. DOI: 10.1056/NEJMc2011117.
    [5] KENNEDY J. Vaccine hesitancy: a growing concern[J]. Paediatr Drugs, 2020, 22(2): 105-111. DOI: 10.1007/s40272-020-00385-4.
    [6] DANZIGER-ISAKOV L, KUMAR D, AST ID Community of Practice. Vaccination of solid organ transplant candidates and recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice[J]. Clin Transplant, 2019, 33(9): e13563. DOI: 10.1111/ctr.13563.
    [7] 徐胜勇, 张秋彬, 李克莉, 等. 疫苗接种不良事件紧急处理中国急诊专家共识[J]. 中国急救医学, 2021, 41(2): 93-100.

    XU SY, ZHANG QB, LI KL, et al. Consensus of Chinese emergency experts on emergency management of vaccination adverse events[J]. Chin J Crit Care, 2021, 41(2): 93-100.
    [8] Guidelines for vaccination of solid organ transplant candidates and recipients[J]. Am J Transplant, 2004, 4(Suppl 10): 160-163. DOI: 10.1111/j.1600-6135.2004.00737.x.
    [9] AVERY RK, MICHAELS M. Update on immunizations in solid organ transplant recipients: what clinicians need to know[J]. Am J Transplant, 2008, 8(1): 9-14. DOI: 10.1111/j.1600-6143.2007.02051.x.
    [10] RUBIN LG, LEVIN MJ, LJUNGMAN P, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host[J]. Clin Infect Dis, 2014, 58(3): 309-318. DOI: 10.1093/cid/cit816.
    [11] KUMAR D, FERREIRA VH, BLUMBERG E, et al. A 5-year prospective multicenter evaluation of influenza infection in transplant recipients[J]. Clin Infect Dis, 2018, 67(9): 1322-1329. DOI: 10.1093/cid/ciy294.
    [12] 国家免疫规划技术工作组流感疫苗工作组. 中国流感疫苗预防接种技术指南(2020-2021)[J]. 中华流行病学杂志, 2020, 41(10): 1555-1576. DOI: 10.3760/cma.j.cn112338-20200904-01126.

    Influenza Vaccine Working Group of National Immunization Program Technical Working Group. Technical guidelines for seasonal influenza vaccination in China (2020-2021)[J]. Chin J Epidemiol, 2020, 41(10): 1555-1576. DOI: 10.3760/cma.j.cn112338-20200904-01126.
    [13] DENDLE C, STUART RL, MULLEY WR, et al. Pneumococcal vaccination in adult solid organ transplant recipients: a review of current evidence[J]. Vaccine, 2018, 36(42): 6253-6261. DOI: 10.1016/j.vaccine.2018.08.069.
    [14] ERIKSSON M, KÄYHTY H, SAHA H, et al. A randomized, controlled trial comparing the immunogenecity and safety of a 23-valent pneumococcal polysaccharide vaccination to a repeated dose 13-valent pneumococcal conjugate vaccination in kidney transplant recipients[J]. Transpl Infect Dis, 2020, 22(4): e13343. DOI: 10.1111/tid.13343.
    [15] 中华预防医学会, 中华预防医学会疫苗与免疫分会. 肺炎球菌性疾病免疫预防专家共识(2020版)[J]. 中华流行病学杂志, 2020, 41(12): 1945-1979. DOI: 10.3760/cma.j.cn112338-20201111-01322.

    Chinese Preventive Medicine Association, Vaccine and Immunology Branch of the Chinese Preventive Medicine Association. Expert consensus on immunoprophylaxis of pneumococcal disease (2020 version)[J]. Chin J Epidemiol, 2020, 41(12): 1945-1979. DOI: 10.3760/cma.j.cn112338-20201111-01322.
    [16] MILLER-HANDLEY H, PAULSEN G, HOOPER DK, et al. Durability of the hepatitis B vaccination in pediatric renal transplant recipients[J]. Clin Transplant, 2018, 32(5): e13247. DOI: 10.1111/ctr.13247.
    [17] MOAL V, MOTTE A, VACHER-COPONAT H, et al. Considerable decrease in antibodies against hepatitis B surface antigen following kidney transplantation[J]. J Clin Virol, 2015, 68: 32-36. DOI: 10.1016/j.jcv.2015.04.011.
    [18] WATKINS SL, ALEXANDER SR, BREWER ED, et al. Response to recombinant hepatitis B vaccine in children and adolescents with chronic renal failure[J]. Am J Kidney Dis, 2002, 40(2): 365-372. DOI: 10.1053/ajkd.2002.34521.
    [19] GÜNTHER M, STARK K, NEUHAUS R, et al. Rapid decline of antibodies after hepatitis A immunization in liver and renal transplant recipients[J]. Transplantation, 2001, 71(3): 477-479. DOI: 10.1097/00007890-200102150-00023.
    [20] 中国疾病预防控制中心. 狂犬病预防控制技术指南(2016版)[J]. 中国病毒病杂志, 2016, 6(3): 161-188. https://www.cnki.com.cn/Article/CJFDTOTAL-ZRYX201603001.htm

    Chinese Center for Disease Control and Prevention. Technical guidelines for human rabies prevention and control (2016 edition)[J]. Chin J Viral Dis, 2016, 6(3): 161-188. https://www.cnki.com.cn/Article/CJFDTOTAL-ZRYX201603001.htm
    [21] 王传林, 刘斯, 邵祝军, 等. 外伤后破伤风疫苗和被动免疫制剂使用指南[J]. 中国疫苗和免疫, 2020, 26(1): 111-115, 127. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGJM202001023.htm

    WANG CL, LIU S, SHAO ZJ, et al. Guidelines for post-traumatic use of tetanus vaccines and passive immune preparations[J]. Chin J Vaccin Immun, 2020, 26(1): 111-115, 127. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGJM202001023.htm
    [22] LARSEN HK, THOMSEN LT, HAEDERSDAL M, et al. Risk of genital warts in renal transplant recipients-a registry-based, prospective cohort study[J]. Am J Transplant, 2019, 19(1): 156-165. DOI: 10.1111/ajt.15056.
    [23] AZZI Y, BARTASH R, SCALEA J, et al. COVID-19 and solid organ transplantation: a review article[J]. Transplantation, 2021, 105(1): 37-55. DOI: 10.1097/TP.0000000000003523.
    [24] NASRALLAH MM, OSMAN NA, ELALFY M, et al. Transplantation in the era of the COVID-19 pandemic: how should transplant patients and programs be handled?[J]. Rev Med Virol, 2021, 31(1): 1-9. DOI: 10.1002/rmv.2149.
    [25] RAJA MA, MENDOZA MA, VILLAVICENCIO A, et al. COVID-19 in solid organ transplant recipients: a systematic review and Meta-analysis of current literature[J]. Transplant Rev (Orlando), 2021, 35(1): 100588. DOI: 10.1016/j.trre.2020.100588.
    [26] TID COVID-19 guidance focused review: SARS-CoV-2 vaccines in transplant recipients[EB/OL]. [2021-09-30]. https://tts.org/26-tid/tid-resources/850-tid-covid-19-guidance-focused-review-sars-cov-2-vaccines-in-transplant-recipients.
    [27] BOYARSKY BJ, WERBEL WA, AVERY RK, et al. Immunogenicity of a single dose of SARS-CoV-2 messenger RNA vaccine in solid organ transplant recipients[J]. JAMA, 2021, 325(17): 1784-1786. DOI: 10.1001/jama.2021.4385.
    [28] BENOTMANE I, GAUTIER-VARGAS G, COGNARD N, et al. Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine[J]. Kidney Int, 2021, 99(6): 1498-1500. DOI: 10.1016/j.kint.2021.04.005.
    [29] KAMAR N, ABRAVANEL F, MARION O, et al. Three doses of an mRNA COVID-19 vaccine in solid-organ transplant recipients[J]. N Engl J Med, 2021, 385(7): 661-662. DOI: 10.1056/NEJMc2108861.
    [30] ALEJO JL, MITCHELL J, CHIANG TP, et al. Antibody response to a fourth dose of a SARS-CoV-2 vaccine in solid organ transplant recipients: a case series[J]. Transplantation, 2021, 105(12): e280-e281. DOI: 10.1097/TP.0000000000003934.
    [31] BOYARSKY BJ, OU MT, GREENBERG RS, et al. Safety of the first dose of SARS-CoV-2 vaccination in solid organ transplant recipients[J]. Transplantation, 2021, 105(5): e56-e57. DOI: 10.1097/TP.0000000000003654.
    [32] OU MT, BOYARSKY BJ, CHIANG TPY, et al. Immunogenicity and reactogenicity after SARS-CoV-2 mRNA vaccination in kidney transplant recipients taking belatacept[J]. Transplantation, 2021, 105(9): 2119-2123. DOI: 10.1097/TP.0000000000003824.
    [33] OU MT, BOYARSKY BJ, MOTTER JD, et al. Safety and reactogenicity of 2 doses of SARS-CoV-2 vaccination in solid organ transplant recipients[J]. Transplantation, 2021, 105(10): 2170-2174. DOI: 10.1097/TP.0000000000003780.
    [34] AL KAABI N, ZHANG Y, XIA S, et al. Effect of 2 inactivated SARS-CoV-2 vaccines on symptomatic COVID-19 infection in adults: a randomized clinical trial[J]. JAMA, 2021, 326(1): 35-45. DOI: 10.1001/jama.2021.8565.
    [35] JARA A, UNDURRAGA EA, GONZÁLEZ C, et al. Effectiveness of an inactivated SARS-CoV-2 vaccine in Chile[J]. N Engl J Med, 2021, 385(10): 875-884. DOI: 10.1056/NEJMoa2107715.
    [36] 疾病预防控制局. 新冠病毒疫苗接种技术指南(第一版)[EB/OL]. [2021-09-30]. http://www.nhc.gov.cn/jkj/s3582/202103/c2febfd04fc5498f916b1be080905771.shtml.
    [37] Centers for disease control and prevention[EB/OL]. [2021-09-30]. https://www.cdc.gov/DataStatistics/.
    [38] ESOT congress 2021[EB/OL]. [2021-09-30]. https://www.esotcongress.org/.
  • 加载中
图(1)
计量
  • 文章访问数:  336
  • HTML全文浏览量:  102
  • PDF下载量:  59
  • 被引次数: 0
出版历程
  • 收稿日期:  2021-10-08
  • 网络出版日期:  2022-01-12
  • 刊出日期:  2022-01-15

目录

    /

    返回文章
    返回